ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GLLI Globalink Investment Inc

11.20
0.00 (0.00%)
04 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Globalink Investment Inc NASDAQ:GLLI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.20 11.09 12.09 1 21:00:01

Current Report Filing (8-k)

22/12/2022 9:32pm

Edgar (US Regulatory)


0001888734 false 0001888734 2022-12-20 2022-12-20 0001888734 us-gaap:CommonStockMember 2022-12-20 2022-12-20 0001888734 GLLI:WarrantsMember 2022-12-20 2022-12-20 0001888734 us-gaap:RightsMember 2022-12-20 2022-12-20 0001888734 GLLI:UnitsMember 2022-12-20 2022-12-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

December 20, 2022

Date of Report (Date of earliest event reported)

 

GLOBALINK INVESTMENT INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-41122   36-4984573
(State or other jurisdiction
of incorporation)
 

(Commission

File Number)

  (I.R.S. Employer
Identification No.)

 

1180 Avenue of the Americas, 8th Floor

New York

  10036
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 212-382-4605

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   GLLI   The Nasdaq Stock Market LLC
Warrants   GLLIW   The Nasdaq Stock Market LLC
Rights   GLLIR   The Nasdaq Stock Market LLC
Units   GLLIU   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

 

On December 20, 2022, Globalink Investment Inc. (the “Company”) received a comment letter (the “Comment Letter”) from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “SEC”). The Staff noted that the Company had filed an amended Forms 10-K for the period ended December 31, 2021, and amended Forms 10-Q for the periods ended March 30, 2022 and June 30, 2022 to restate the Company’s previously issued financial statements. Accordingly, the Company was asked to file an Item 4.02 8-K indicating that the Company’s previously issued financial statements, and related audit report, should no longer be relied upon.

 

On November 10, 2022, the Company’s audit committee (the “Audit Committee”), based on the recommendation of, and after consultation with, the Company’s management, and as discussed with Friedman LLP (“Friedman”), the Company’s independent registered public accounting firm for the previously issued financial statements, concluded that the Company’s audited financial statements as reported in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC on March 31, 2022 (the “Form 10-K”), the quarterly report on Form 10-Q for the period ended March 31, 2022 filed with the SEC on May 16, 2022 (the “Form 10-Q1”); and the quarterly report on Form 10-Q for the period ended June 30, 2022 filed with the SEC on August 15, 2022 (the “Form 10-Q2”) should no longer be relied upon due to the misclassification of the Company’s outstanding warrants as components of equity instead of as liabilities (the “Non-Reliance Period”). Similarly, the audit report of Friedman dated March 31, 2022 and included in the Form 10-K, and any communications describing relevant portions of the Company’s financial statements for the Non-Reliance Period, should no longer be relied upon.

 

As a result, the Company restated its historical financial results for the Non-Reliance Period to reflect the classification of the warrants as liabilities (the “Restatement”).

 

On December 5, 2022, the Company filed an amendment to the Form 10-K, an amendment to the Form 10-Q1, and an amended to the Form 10-Q2 to reflect the Restatement. Going forward, unless the Company amends the terms of its warrant agreement, the Company expects to continue to classify the warrants as a liability, which would require the Company to incur the cost of measuring the fair value of the warrant liabilities, and which may have an adverse effect on the Company’s results of operations. While the Company has not generated any operating revenues to date and will not generate any operating revenues until after completion of its initial business combination, at the earliest, the change in fair value of the warrants is a non-cash charge and will be reflected in the Company’s statement of operations. The Audit Committee and management of the Company have discussed the matters disclosed pursuant to this Item 4.02 with Friedman.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: December 22, 2022  
   
GLOBALINK INVESTMENT INC.  
   
By: /s/ Say Leong Lim  
Name: Say Leong Lim  
Title: Chief Executive Officer  

 

 

 

1 Year Globalink Investment Chart

1 Year Globalink Investment Chart

1 Month Globalink Investment Chart

1 Month Globalink Investment Chart